«

»

Apr 20

US health regulators have recently approved four Boston Scientific Corp implantable devices for heart patients

US health regulators have recently approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms. The devices include Dynagen Mini and Inogen Mini implantable cardioverter defibrillators (ICDs) and the Dynagen X4 and Inogen X4 cardiac resynchronization therapy defibrillators (CRT–Ds).

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>